Revolution Medicines, Inc. is 19.0x more valuable than RECURSION PHARMACEUTICALS, INC. by market capitalization ($30.65 B vs $1.61 B). Every figure below comes from audited SEC filings and refreshed market data.
| Metric | RXRX | RVMD |
|---|---|---|
| Market cap | $1.61 B | $30.65 B |
| US-listed rank | #2258 | #454 |
| Revenue (latest FY) | $74.68M | $0.00 |
| Net income (latest FY) | -$644.76M | -$1.13B |
| Net margin | -863.4% | - |
| SEC filings | 908 | 782 |
Revolution Medicines, Inc. is 19.0x more valuable than RECURSION PHARMACEUTICALS, INC. by market capitalization ($30.65 B vs $1.61 B).
In their latest fiscal years, RECURSION PHARMACEUTICALS, INC. reported $74.68M in revenue while Revolution Medicines, Inc. reported $0.00.
Full pages: RECURSION PHARMACEUTICALS, INC. and Revolution Medicines, Inc., or browse the full rankings.